A population-based case-control study of urinary bisphenol A concentrations and risk of endometriosis

Human Reproduction

Volumn 29, Issue 11, 2014, Pages 2457-2464

  Upson, Kristen ^a,b,c   Sathyanarayana, Sheela ^a,d,e   De Roos, Anneclaire J ^f   Koch, Holger M ^g   Scholes, Delia ^a,h   Holt, Victoria L ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^f DREXEL UNIVERSITY   (United States)

^g RUHR UNIVERSITY BOCHUM   (Germany)

^h GROUP HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Bisphenol A; endometriosis; environmental health; epidemiology; population based case control study

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CREATININE; BENZHYDRYL DERIVATIVE; PHENOL DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; ELIMINATION HALF-LIFE; ENDOMETRIOSIS; FEMALE; HEALTH CARE SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MENSTRUAL CYCLE; POPULATION BASED CASE CONTROL STUDY; RISK; SAMPLE SIZE; URINALYSIS; CASE CONTROL STUDY; MIDDLE AGED; RISK FACTOR; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; BENZHYDRYL COMPOUNDS; CASE-CONTROL STUDIES; ENDOMETRIOSIS; FEMALE; HUMANS; MIDDLE AGED; PHENOLS; RISK FACTORS; YOUNG ADULT;

EID: 84913528138     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu227     Document Type: Article

References (49)

1. Aldad TS, Rahmani N, Leranth C, Taylor HS. Bisphenol-A exposure alters endometrial progesterone receptor expression in the nonhuman primate. Fertil Steril 2011;96:175-179.
2. Attia GR, Zeitoun K, Edwards D, Johns A, Carr BR, Bulun SE. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab 2000;85:2897-2902.
3. Barr DB,Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 2005; 113:192-200.
4. Bergqvist A, Ferno M. Oestrogen and progesterone receptors in endometriotic tissue and endometrium: comparison of different cycle phases and ages. Hum Reprod 1993;8:2211-2217.
5. Birnbaum LS, Jung P. From endocrine disruptors to nanomaterials: advancing our understanding of environmental health to protect public health. Health Aff (Millwood) 2011;30:814-822.
6. Braun JM, Smith KW, Williams PL, Calafat AM, Berry K, Ehrlich S, Hauser R. Variability of urinary phthalate metabolite and bisphenol A concentrations before and during pregnancy. Environ Health Perspect 2012;120:739-745.
7. Buck Louis GM, Hediger ML, Peterson CM, Croughan M, Sundaram R, Stanford J, Chen Z, Fujimoto VY, Varner MW, Trumble A et al. Incidence of endometriosis by study population and diagnostic method: the ENDO study. Fertil Steril 2011;96:360-365.
8. Buck Louis GM, Peterson CM, Chen Z, Croughan M, Sundaram R, Stanford J, Varner MW, Kennedy A, Giudice L, Fujimoto VY et al. Bisphenol A and phthalates and endometriosis: the Endometriosis: Natural History, Diagnosis and Outcomes Study. Fertil Steril 2013;100:162-169.
9. Calafat AM, Ye X,Wong LY, Reidy JA, Needham LL. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 2008;116:39-44.
10. Calafat AM, Koch HM, Swan SH, Hauser R, Goldman LR, Lanphear BP, Longnecker MP, Rudel RA, Teitelbaum SL, Whyatt RM et al. Misuse of blood serum to assess exposure to bisphenol A and phthalates. Breast Cancer Res 2013;15:403.
11. Chapin RE, Adams J, Boekelheide K, Gray LE Jr, Hayward SW, Lees PS, McIntyre BS, Portier KM, Schnorr TM, Selevan SG et al. NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. Birth Defects Res B Dev Reprod Toxicol 2008;83:157-395.
12. Cobellis L, Colacurci N, Trabucco E, Carpentiero C, Grumetto L. Measurement of bisphenol A and bisphenol B levels in human blood sera from healthy and endometriotic women. Biomed Chromatogr 2009; 23:1186-1190.
13. Dodds EC, Lawson W. Synthetic oestrogenic agents without the phenanthrene nucleus. Nature 1936;137:996.
14. EFSA. European Food Safety Authority. Opinion of the Scientific Panelon Food Additives, Flavourings, Processing Aids, and Materials in Contact with Food on a request from the Commission related to 2,2-bis(4-hydroxyphenyl) propane (Bisphenol A). Question number EFSA-Q-2005-100. 2006.
15. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology 1999;10:37-48.
16. Gruppo italiano per lo studio dell'endometriosi. Prevalence and anatomical distribution of endometriosis in women with selected gynaecological conditions: results from a multicentric Italian study. Hum Reprod 1994; 9:1158-1162.
17. Hernan MA, Hernandez-Diaz S,WerlerMM,Mitchell AA. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol 2002;155:176-184.
18. Holt VL, Weiss NS. Recommendations for the design of epidemiologic studies of endometriosis. Epidemiology 2000;11:654-659.
19. Honma S, Suzuki A, Buchanan DL, Katsu Y,Watanabe H, Iguchi T. Low dose effect of in utero exposure to bisphenol A and diethylstilbestrol on female mouse reproduction. Reprod Toxicol 2002;16:117-122.
20. Houston DE, Noller KL, Melton LJ III, Selwyn BJ, Hardy RJ. Incidence of pelvic endometriosis in Rochester, Minnesota, 1970-1979.AmJ Epidemiol 1987; 125:959-969.
21. Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS. Exposure to bisphenol A advances puberty. Nature 1999; 401:763-764.
22. Itoh H, Iwasaki M, Hanaoka T, Sasaki H, Tanaka T, Tsugane S. Urinary bisphenol-a concentration in infertile Japanese women and its association with endometriosis: a cross-sectional study. Environ Health Prev Med 2007;12:258-264.
23. Koch HM, Calafat AM. Human body burdens of chemicals used in plastic manufacture. Philos Trans R Soc Lond B Biol Sci 2009; 364:2063-2078.
24. Koch HM, Kolossa-Gehring M, Schroter-Kermani C, Angerer J, Bruning T. Bisphenol A in 24h urine and plasma samples of the German Environmental Specimen Bank from 1995 to 2009: a retrospective exposure evaluation. J Expo Sci Environ Epidemiol 2012;22:610-616.
25. Koninckx PR, Oosterlynck D, D'Hooghe T, Meuleman C. Deeply infiltrating endometriosis is a disease whereas mild endometriosis could be considered a non-disease. Ann N Y Acad Sci 1994;734:333-341.
26. Longnecker MP, Harbak K, Kissling GE, Hoppin JA, Eggesbo M, Jusko TA, Eide J, Koch HM. The concentration of bisphenol A in urine is affected by specimen collection, a preservative, and handling. Environ Res 2013; 126:211-214.
27. Lubin JH, Colt JS, Camann D, Davis S, Cerhan JR, Severson RK, Bernstein L, Hartge P. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect 2004;112:1691-1696.
28. Marino JL, Holt VL, Chen C, Davis S. Shift work, hCLOCK T3111C polymorphism, and endometriosis risk. Epidemiology 2008;19:477-484.
29. Marino JL, Holt VL, Chen C, Davis S. Lifetime occupational history and risk of endometriosis. Scand JWork Environ Health 2009;35:233-240.
30. Markey CM, Coombs MA, Sonnenschein C, Soto AM. Mammalian development in a changing environment: exposure to endocrine disruptors reveals the developmental plasticity of steroid-hormone target organs. Evol Dev 2003;5:67-75.
31. Mathias SD, Kuppermann M, Liberman RF, Lipschutz RC, Steege JF. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol 1996;87:321-327.
32. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Marshall LM, Hunter DJ. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol 2004; 160:784-796.
33. Nepomnaschy PA, Baird DD, Weinberg CR, Hoppin JA, Longnecker MP, Wilcox AJ. Within-person variability in urinary bisphenol A concentrations: measurements from specimens after long-term frozen storage. Environ Res 2009;109:734-737.
34. Nisolle M, Donnez J. Peritoneal, Ovarian and Recto-Vaginal Endometriosis: The Identification of Three Separate Diseases. Pearl River, New York: The Parthenon Publishing Group Inc., 1997.
35. NTP. NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Bisphenol A. NIH Publication no. 08-5994. 1556-2271 (Print), 2008.
36. Quignot N, Arnaud M, Robidel F, Lecomte A, Tournier M, Cren-Olive C, Barouki R, Lemazurier E. Characterization of endocrine-disrupting chemicals based on hormonal balance disruption in male and female adult rats. Reprod Toxicol 2012;33:339-352.
37. Rosner B. Fundamentals of Biostatistics. 7th edn. Boston: Brooks/Cole, Cengage Learning, 2011.
38. Sangi-Haghpeykar H, Poindexter AN III. Epidemiology of endometriosis among parous women. Obstet Gynecol 1995;85:983-992.
39. Saunders KW, Davis RL, Stergachis A. Chapter 14. Group health cooperative. In: Strom BL (ed.) Pharmacoepidemiology, Part 4th edn. West Sussex, England: JohnWiley & Sons Ltd, 2005, 223-239.
40. Schonfelder G, Friedrich K, Paul M, Chahoud I. Developmental effects of prenatal exposure to bisphenol A on the uterus of rat offspring. Neoplasia 2004;6:584-594.
41. Signorile PG, Spugnini EP, Mita L, Mellone P, D'Avino A, Bianco M, Diano N, Caputo L, Rea F, Viceconte R et al. Pre-natal exposure of mice to bisphenol A elicits an endometriosis-like phenotype in female offspring. Gen Comp Endocrinol 2010;168:318-325.
42. Taussky HH. A microcolorimetric determination of creatine in urine by the Jaffe reaction. J Biol Chem 1954;208:853-861.
43. Townsend MK, Franke AA, Li X, Hu FB, Eliassen AH. Within-person reproducibility of urinary bisphenol A and phthalate metabolites over a 1 to 3year period among women in the Nurses' Health Studies: a prospective cohort study. Environ Health 2013;12:80.
44. UhHW, Hartgers FC, Yazdanbakhsh M, Houwing-Duistermaat JJ. Evaluation of regression methods when immunological measurements are constrained by detection limits. BMC Immunol 2008;9:59.
45. Upson K, De Roos AJ, Thompson ML, Sathyanarayana S, Scholes D, Barr DB, Holt VL. Organochlorine pesticides and risk of endometriosis: findings from a population-based case-control study. Environ Health Perspect 2013a;121:1319-1324.
46. Upson K, Sathyanarayana S, De Roos AJ, Thompson ML, Scholes D, Dills R, HoltVL.Phthalates and riskof endometriosis. Environ Res 2013b;126:91-97.
47. Volkel W, Colnot T, Csanady GA, Filser JG, Dekant W. Metabolism and kinetics of bisphenol A in humans at low doses following oral administration. Chem Res Toxicol 2002;15:1281-1287.
48. Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, Sonnenschein C, Watson CS, Zoeller RT, Belcher SM. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 2007;24:178-198.
49. Weuve J, Hauser R, Calafat AM, Missmer SA, Wise LA. Association of exposure to phthalates with endometriosis and uterine leiomyomata: findings from NHANES, 1999-2004. Environ Health Perspect 2010; 118:825-832.